ETRAVIRINE 200 MG TABLET

etravirine
$11.3233per EA

Strength

200 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452025517

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ETRAVIRINE

Approval Type

Generic (ANDA)

FDA Application

ANDA219152

On Market Since

1/1/2026

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
P-Glycoprotein Inhibitors

Price History

1W

0.0%

1M

-1.5%

3M

-3.3%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-3.3%